News & Events.

Trendlines Medical Singapore forms partnership with A*ccelerate

Goal of the partnership: to jointly develop and commercialize medical technologies

11 November 2018


Trendlines Medical Singapore entered into a Memorandum of Understanding (MOU) with Accelerate Technologies (A*ccelerate) to collaborate and explore potential joint R&D initiatives in several medical technology areas.

Under the MOU, Trendlines Medical Singapore and A*ccelerate will work together to identify technology from A*STAR with the intention of spinning-off up to five start-up companies that will benefit from Trendlines Medical Singapore’s expertise in medical device incubation and A*ccelerate’s technology development capability.

Trendlines Medical Singapore and A*ccelerate have identified projects in the field of ultrasound-guided therapies, neurorehabilitation, radiology, ophthalmology, urology, and gastroenterology as areas of focus.

Trendlines Medical Singapore portfolio company Medulla Pro is developing its ultrasound-guided technology in partnership with A*ccelerate.

A*ccelerate is the commercialization arm of the Agency for Science, Technology and Research (A*STAR), Singapore’s lead agency for fostering world-class scientific research and talent.

See More News

19 December 2021

FruitSpec raises $5 million

FruitSpec’s Yield Management Platform provides digital visibility of fruit yield data to entire supply-chain production units

16 September 2020

Phytolon secures $4.1 million in funding

Funding for fermentation-based technology for the production of food colors

Skip to content